Gilead (GILD) Posts Earnings Beat, Total Product Sales See YoY Decline
Gilead Sciences (GILD) just released its fourth quarter fiscal 2017 financial results, posting earnings of $1.78 per share and revenues of $5.95 billion. Shares are down 2.4% to $78.50 in trading shortly after as a result.
Source:: https://finance.yahoo.com/news/gilead-gild-posts-earnings-beat-222410913.html
